Bibliografía

  • Di Simone M P. et al. (2012). Barrier effect of Esoxx® on esophageal mucosal damage: experimental study on ex-vivo swine model. Clinical and Experimental Gastroenterology, 103–107.
  • Du Souich P, e. a. (2009). Immunomodulatory and anti-in ammatory effects of chondroitin sulphate. J. Cell. Mol. Med., 1451–1463.
  • Fakhari A, B. C. (2013). Applications and emerging trends of hyaluronic acid in tissue engineering, as a dermal ller and in osteoarthritis treatment. Acta Biomater, 7081-7092.
  • Gaffney, J. M.-N.-O. (2010). Therapeutic applications of hyaluronan. Molecular biosystems, 437-443.
  • Kessiena L, e. a. (2014). Hyaluronan in wound healing: Rediscovering a major player. Wound Repair and regeneration, 579-593.
  • Kevin T. Dicker, L. A.-B.-C. (2014). Hyaluronan: A simple polysaccharide with diverse biological functions. Acta Biomaterialia, 1558-1570.
  • Lauder, R. (2009). Chondroitin sulphate: A complex molecule with potential impacts on a wide range of biological systems. Complementary therapies in Medicine, 56-62.
  • Palmieri, B. e. (2013). Fixed combination of hyaluronic acid and chondroitin-sulphate oral formulation in a randomized double blind, placebo controlled study for the treatment of symptoms in patients with non-erosive gastroesophageal re ux.
  • European Review for Medical and Pharmacological Sciences, 3272-3278.
  • Prasad N, e. a. (2014). Bene cial Effects of Hyaluronic Acid. En Prasad N, Advances in Food and Nutrition (págs. 138-168). USA: Elsevier Inc.
  • Schnabelrauch M, e. a. (2013). Sulfated Glycosaminoglycans As Promising Arti cial Extracellular Matrix Components to Improve the Regeneration of Tissues. Current Medicinal Chemistry, 2501-2523.
  • Scott, R. A. (2013). Glycosaminoglycans in biomedicine. WIREs Nanomed Nanobiotechnoly, 388-398.